Health ❯ Healthcare ❯ Prescription Drugs

Drug Pricing

Medicare Consumer Access Pharmaceutical Companies Pfizer Cost Reduction Strategies Discount Programs Medicare Negotiation Program Pharmaceutical Industry Insulin Pricing Affordability Negotiation Process Government Regulation Generic Drugs Medicare Rebates Consumer Impact Regulatory Actions Cost Reduction Medicare and Medicaid Cost Regulation Executive Orders Market Regulation Insurance Coverage Price Caps GLP-1 Agonists Over-the-Counter Medications Medicare Price Negotiations Generic vs Brand Name Regeneron

Drug-Cost Anxiety Hits New High in KFF Poll as TrumpRx Sees Limited Reach

Democrats now lead on voter trust to address prescription prices.

Lawmakers Seek Transparency as TrumpRx Faces Questions on Who Saves

TrumpRx Debuts With 43 Discounted Brand Drugs as Analyses Flag Cheaper Generics and Limits

Colorado Sets First State Drug Price Cap, Limits Enbrel to $600 Per 50 mg Dose